Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 9
Submit an article Journal homepage
445
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Wilms’ tumor 1 gene in hematopoietic malignancies: clinical implications and future directions

Ping LuoDepartment of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China; View further author information
,
Wei JingDepartment of Clinical Laboratory, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; View further author information
,
Kezhen YiDepartment of Clinical Laboratory Medicine & Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, ChinaView further author information
,
Sanyun WuDepartment of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China; View further author information
&
Fuling ZhouDepartment of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China; Correspondence[email protected]
View further author information
Pages 2059-2067 | Received 04 Feb 2020, Accepted 26 Apr 2020, Published online: 13 May 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jie Wu, Hui Yan & Chunli Xiang. (2023) Wilms’ tumor gene 1 in hematological malignancies: friend or foe?. Hematology 28:1.
Read now
Ting Wang, Haiying Hua, Zheng Wang, Biao Wang, Liujun Cao, Wei Qin, Pin Wu, Xiaohui Cai, Hongying Chao & XuZhang Lu. (2022) Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia. Hematology 27:1, pages 994-1002.
Read now

Articles from other publishers (5)

Futoon Abedrabbu Al-Rawashde, Ola M. Al-Sanabra, Moath Alqaraleh, Ahmad Q. Jaradat, Abdullah Saleh Al-Wajeeh, Muhammad Farid Johan, Wan Rohani Wan Taib, Imilia Ismail & Hamid Ali Nagi Al-Jamal. (2023) Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway. Pharmaceuticals 16:6, pages 884.
Crossref
Y. J. Jing, L. C. Lin, L. L. Chen, Z. E. Huang, H. C. Qin, S. B. Li & Z. H. Chen. (2022) WT1 Inhibits Human Renal Carcinoma Cell Proliferation and Induces G2/M Arrest by Upregulating IL-24 Expression. BioMed Research International 2022, pages 1-16.
Crossref
Jochen Greiner, Marlies Götz & Verena Wais. (2022) Increasing Role of Targeted Immunotherapies in the Treatment of AML. International Journal of Molecular Sciences 23:6, pages 3304.
Crossref
Maiko Matsushita. (2021) Novel Treatment Strategies Utilizing Immune Reactions against Chronic Myelogenous Leukemia Stem Cells. Cancers 13:21, pages 5435.
Crossref
Lok Lam Ngai, Angèle Kelder, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele & Jacqueline Cloos. (2021) MRD Tailored Therapy in AML: What We Have Learned So Far. Frontiers in Oncology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.